OOIR: Observatory of International Research

Papers

(The H4-Index of Radiotherapy and Oncology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Contents	168
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	130
529 Current standard of care treatment in non-metastatic cervix cancer	123
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	104
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	101
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	93
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	83
525 Proton and carbon therapy: recent technological advances	80
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	80
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	80
45 Stereotactic radiosurgery for tremor: a center experience.	78
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	78
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	76
Corrigendum to “Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing” [Radiother. Oncol. 200 (2024) 110477]	74
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	73
157 Adaptive radiation therapy	70
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	66
480 Addressing the education and training needs of RTT in particle radiation therapy	66
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	63
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	58
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	57
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	57
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	56
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	54
3429: Modulating innate immunity by DNA damage response inhibition	52

1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	52
749: Reinforcement learning for accelerated automatic treatment planning optimization	51
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	51
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	51
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	51
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	50
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	50
1635: In vivo dosimetry - keeping my finger on the pulse	50
1861: Performance of a heart substructures autocontouring tool after clinical implementation	49
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	48
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	48
3201: Dosimetric properties of flexible 3D-printed boluses	47
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	47
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	46
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	46
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	45
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	44
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	44
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	44